Suppr超能文献

动物冠状病毒与 SARS-CoV-2。

Animal coronaviruses and SARS-CoV-2.

机构信息

Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.

Scientific Observation and Experiment Station of Veterinary Drugs and Diagnostic Technology of Beijing, Ministry of Agriculture, Beijing, China.

出版信息

Transbound Emerg Dis. 2021 May;68(3):1097-1110. doi: 10.1111/tbed.13791. Epub 2020 Sep 9.

Abstract

COVID-19 is a highly contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has rapidly spread to 216 countries and territories since first outbreak in December of 2019, posing a substantial economic losses and extraordinary threats to the public health worldwide. Although bats have been suggested as the natural host of SARS-CoV-2, transmission chains of this virus, role of animals during cross-species transmission, and future concerns remain unclear. Diverse animal coronaviruses have extensively been studied since the discovery of avian coronavirus in 1930s. The current article comprehensively reviews and discusses the current understanding about animal coronaviruses and SARS-CoV-2 for their emergence, transmission, zoonotic potential, alteration of tissue/host tropism, evolution, status of vaccines and surveillance. This study aims at providing guidance for control of COVID-19 and preventative strategies for possible future outbreaks of zoonotic coronavirus via cross-species transmission.

摘要

新型冠状病毒肺炎(COVID-19)是由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的一种高传染性疾病。自 2019 年 12 月首次爆发以来,该病毒迅速传播到 216 个国家和地区,对全球公共卫生造成了巨大的经济损失和巨大的威胁。虽然蝙蝠被认为是 SARS-CoV-2 的天然宿主,但该病毒的传播链、动物在跨物种传播中的作用以及未来的关注点仍不清楚。自 20 世纪 30 年代发现禽冠状病毒以来,人们对各种动物冠状病毒进行了广泛研究。本文全面综述和讨论了动物冠状病毒和 SARS-CoV-2 的出现、传播、人畜共患潜力、组织/宿主嗜性改变、进化、疫苗和监测现状。本研究旨在为控制 COVID-19 以及预防可能通过跨物种传播发生的人畜共患冠状病毒未来爆发提供指导。

相似文献

1
Animal coronaviruses and SARS-CoV-2.
Transbound Emerg Dis. 2021 May;68(3):1097-1110. doi: 10.1111/tbed.13791. Epub 2020 Sep 9.
2
Bat origin of human coronaviruses.
Virol J. 2015 Dec 22;12:221. doi: 10.1186/s12985-015-0422-1.
5
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26.
6
Zoonotic evolution and implications of microbiome in viral transmission and infection.
Virus Res. 2020 Dec;290:198175. doi: 10.1016/j.virusres.2020.198175. Epub 2020 Sep 29.
7
SARS-CoV-2: a new dimension to our understanding of coronaviruses.
Int Microbiol. 2021 Jan;24(1):19-24. doi: 10.1007/s10123-020-00152-y. Epub 2020 Nov 24.
10
Molecular diversity of coronavirus host cell entry receptors.
FEMS Microbiol Rev. 2021 May 5;45(3). doi: 10.1093/femsre/fuaa057.

引用本文的文献

3
Presence of anti-SARS-CoV-2 antibodies in European bison (Bison bonasus) in Poland, 2019-2023.
BMC Vet Res. 2025 Feb 28;21(1):120. doi: 10.1186/s12917-025-04593-3.
5
Cross-Species Surveillance of Respiratory Viruses in Domestic and Wild Mammals of an Urban Atlantic Forest from Brazil.
Ecohealth. 2025 Mar;22(1):11-28. doi: 10.1007/s10393-024-01691-w. Epub 2025 Feb 4.
7
Feline Infectious Peritonitis mRNA Vaccine Elicits Both Humoral and Cellular Immune Responses in Mice.
Vaccines (Basel). 2024 Jun 24;12(7):705. doi: 10.3390/vaccines12070705.
8
Antigen epitopes of animal coronaviruses: a mini-review.
Anim Dis. 2023;3(1):14. doi: 10.1186/s44149-023-00080-0. Epub 2023 May 17.
9
Reprogramming viral immune evasion for a rational design of next-generation vaccines for RNA viruses.
Front Immunol. 2023 Apr 17;14:1172000. doi: 10.3389/fimmu.2023.1172000. eCollection 2023.
10
Cervids ACE2 Residues that Bind the Spike Protein can Provide Susceptibility to SARS-CoV-2.
Ecohealth. 2023 Mar;20(1):9-17. doi: 10.1007/s10393-023-01632-z. Epub 2023 Apr 27.

本文引用的文献

1
On the origin and continuing evolution of SARS-CoV-2.
Natl Sci Rev. 2020 Jun;7(6):1012-1023. doi: 10.1093/nsr/nwaa036. Epub 2020 Mar 3.
2
Binding of the SARS-CoV-2 spike protein to glycans.
Sci Bull (Beijing). 2021 Jun 30;66(12):1205-1214. doi: 10.1016/j.scib.2021.01.010. Epub 2021 Jan 19.
3
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.
Nat Commun. 2020 Nov 26;11(1):6013. doi: 10.1038/s41467-020-19808-4.
4
Emergence of SARS-CoV-2 through recombination and strong purifying selection.
Sci Adv. 2020 Jul 1;6(27). doi: 10.1126/sciadv.abb9153. Print 2020 Jul.
5
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2.
Cell. 2020 Aug 6;182(3):713-721.e9. doi: 10.1016/j.cell.2020.06.008. Epub 2020 Jun 6.
7
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
Cell. 2020 Aug 20;182(4):812-827.e19. doi: 10.1016/j.cell.2020.06.043. Epub 2020 Jul 3.
8
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
N Engl J Med. 2020 Nov 12;383(20):1920-1931. doi: 10.1056/NEJMoa2022483. Epub 2020 Jul 14.
9
Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020.
Euro Surveill. 2020 Jul;25(26). doi: 10.2807/1560-7917.ES.2020.25.26.2001200.
10
SARS-CoV-2 infection in farmed minks, the Netherlands, April and May 2020.
Euro Surveill. 2020 Jun;25(23). doi: 10.2807/1560-7917.ES.2020.25.23.2001005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验